Korro Bio, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Korro Bio, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2018 to Q2 2024.
  • Korro Bio, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$21.8M, a 23.7% decline year-over-year.
  • Korro Bio, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$85.3M, a 68.5% decline year-over-year.
  • Korro Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$81.2M, a 39.9% decline from 2022.
  • Korro Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$58M, a 31.5% increase from 2021.
  • Korro Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$84.7M, a 219% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$85.3M -$21.8M -$4.18M -23.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$81.1M -$19.6M +$48K +0.25% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-13
Q4 2023 -$81.2M -$32.3M -$38.5M -622% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 -$42.7M -$11.6M +$7.93M +40.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 -$50.6M -$17.6M +$3.64M +17.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$54.3M -$19.6M +$3.78M +16.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-13
Q4 2022 -$58M $6.19M +$27.7M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 -$85.7M -$19.5M +$5.61M +22.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$91.3M -$21.3M -$3.63M -20.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$87.7M -$23.4M -$3.01M -14.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$84.7M -$21.5M -$11.3M -110% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-10
Q3 2021 -$73.4M -$25.2M -$19.8M -371% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$53.6M -$17.7M -$11.6M -193% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$42M -$20.4M -$15.5M -315% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 -$26.5M -$10.2M -$4.74M -86.3% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-29
Q3 2020 -$21.8M -$5.34M -$4.77M -829% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$17M -$6.03M +$827K +12.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$17.8M -$4.91M +$913K +15.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$18.7M -$5.49M -$46K -0.85% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-29
Q3 2019 -$18.7M -$575K +$4.56M +88.8% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-29
Q2 2019 -$23.3M -$6.85M -$2.42M -54.5% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-29
Q1 2019 -$20.8M -$5.83M -$1.68M -40.4% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-29
Q4 2018 -$19.2M -$5.45M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-26
Q3 2018 -$5.14M Jul 1, 2018 Sep 30, 2018 10-K 2020-03-26
Q2 2018 -$4.44M Apr 1, 2018 Jun 30, 2018 10-K 2020-03-26
Q1 2018 -$4.15M Jan 1, 2018 Mar 31, 2018 10-K 2020-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.